The FDA last year wanted to expedite the review of Compass Pathways’ psilocybin treatment for severe depression as part of a ...

FDA leaders tried to quell concerns about a controversial new program to fast-track certain drugs at an employee town hall ...

Diabetes before or during pregnancy — whether pre-gestational, type 1, or type 2 — was associated with a higher risk of ...

A new study argues that overlap between advisers and advisees on research topics helps rather than hinders young life scientists.

After discovering a drug he took for restless leg syndrome caused compulsive gambling, J. Aaron Sanders found himself facing “existential questions of free will.” ...

Trump administration officials vetoed the FDA's plan to fast-track the review of a psychedelic treatment for severe ...

At an employee town hall, FDA leaders tried to quell staff concerns about a controversial new program to fast-track certain drugs.

The American Society of Plastic Surgeons recommended that gender-affirming surgeries be delayed until a patient is at least 19 years old ...

Novo Nordisk on Tuesday said it expects sales and profits to decline this year, as the maker of Wegovy faces growing ...

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...

Pfizer reported weight-loss results for a monthly GLP-1 obesity injection that it acquired as part of the $10 billion Metsera ...

Pfizer disclosed that an experimental weight loss drug, recently picked up through its acquisition of Metsera, hit its marks ...